Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Jumpcan Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥30.6

2024-10-29

Market Capitalization

¥28.1 B

2024-10-29

Revenue

¥6.1 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue7.1B6.8B6.1B7.5B8.8B9.5B7.9B6.1B
Cost of goods sold1.1B1.1B1.1B1.3B1.5B1.8B1.7B1.3B
Gross profit6.0B5.7B4.9B6.2B7.3B7.7B6.2B4.8B
Gross profit margin, %84.0%83.1%81.4%79.1%78.7%
Operating expense total3.9B3.7B3.3B4.3B4.7B4.5B3.5B2.6B
Depreciation and amortization175.5M231.1M278.9M279.9M304.7M319.0M306.7M309.1M
EBITDA2.1B2.0B1.7B2.0B2.6B3.2B2.7B2.2B
EBITDA margin, %29.9%26.1%33.7%34.3%35.5%
EBIT2.0B1.9B1.4B1.8B2.4B3.0B2.7B1.9B
EBIT margin, %27.3%24.2%31.2%33.8%31.5%
Interest income30.2M53.1M81.7M124.4M117.0M276.1M269.2M66.8M
Interest expense34.1M30.7M33.0M34.9M30.4M17.6M27.3M11.4M
Pre tax profit2.0B1.9B1.5B2.0B2.5B3.3B3.0B2.2B
Income tax expense288.9M270.2M206.3M233.2M336.2M470.0M441.5M384.0M
Net Income1.7B1.6B1.3B1.7B2.2B2.8B2.5B1.8B

Footer menu